Discovery and preclinical development of selective JAK inhibitors for the treatment of hematological malignancies

被引：0
|
作者：
Fridman, S.
Li, J.
Liu, P.
Caulder, E.
Crowgey, E.
Favata, M.
Guoen, G.
Li, Y.
Covington, M.
Rodgers, J.
Combs, A.
Yeleswaram, S.
Newton, R.
Scherle, P.
Vaddi, K.
机构：
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0324
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies
    Liang, Xuewu
    Zang, Jie
    Li, Xiaoyang
    Tang, Shuai
    Huang, Min
    Geng, Meiyu
    Chou, C. James
    Li, Chunpu
    Cao, Yichun
    Xu, Wenfang
    Liu, Hong
    Zhang, Yingjie
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (08) : 3898 - 3923
  • [2] Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignancies
    Zhu, Jingyu
    Hou, Tingjun
    Mao, Xinliang
    DRUG DISCOVERY TODAY, 2015, 20 (08) : 988 - 994
  • [3] Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies
    Upadhayaya, Ram S.
    Kethiri, Raghava Reddy
    Vellanki, Avanish
    Lightfoot, Jeff
    Local, Andrea
    Rice, William G.
    BLOOD, 2016, 128 (22)
  • [4] Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
    Furqan M.
    Mukhi N.
    Lee B.
    Liu D.
    Biomarker Research, 1 (1)
  • [5] Selective inhibitors of nuclear export (SINE) in hematological malignancies
    Das A.
    Wei G.
    Parikh K.
    Liu D.
    Experimental Hematology & Oncology, 4 (1)
  • [6] Syk inhibitors in clinical development for hematological malignancies
    Delong Liu
    Aleksandra Mamorska-Dyga
    Journal of Hematology & Oncology, 10
  • [7] Syk inhibitors in clinical development for hematological malignancies
    Liu, Delong
    Mamorska-Dyga, Aleksandra
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [8] Preclinical Development of Small-Molecule CRM1 Inhibitors as Novel Therapy for the Treatment of Myeloma and Other Hematological Malignancies
    Shacham, Sharon
    Turner, Joel G.
    Nir, Raphael
    Draetta, Giulio
    Sandanayaka, Vincent
    Shechter, Sharon
    Kauffman, Michael
    Sullivan, Daniel
    BLOOD, 2010, 116 (21) : 1241 - 1241
  • [9] Histone deacetylase inhibitors in the treatment of hematological malignancies
    Lemal, Richard
    Ravinet, Aurelie
    Molucon-Chabrot, Cecile
    Bay, Jacques-Olivier
    Guieze, Romain
    BULLETIN DU CANCER, 2011, 98 (08) : 867 - 878
  • [10] Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies
    Petrella, A.
    Fontanella, B.
    Carratu, A.
    Bizzarro, V.
    Rodriquez, M.
    Parente, L.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 519 - 527
12345